Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.87 is 17% below its 5-year average of 7.09, around the middle of its 5-year range (1.33–15.62).
As of the fiscal period ended Tuesday, June 30, 2026. 25.49% above its 12-month average of 4.68.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.87.
CURRENT RATIO
5.87
CURRENT RATIO AVG TTM
4.68
CURRENT RATIO AVG 3Y
4.85
CURRENT RATIO AVG 5Y
7.09
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+25.49%
CURRENT VS 3Y AVG
+21.03%
CURRENT VS 5Y AVG
-17.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+56.51%
vs the sector median at left
Market Cap
$239.02M
Current Ratio
8.28
TTM Avg
3.73
3Y Avg
7.03
5Y Avg
8.20
Market Cap
$235.97M
Current Ratio
21.72
TTM Avg
10.47
3Y Avg
8.50
5Y Avg
9.09
Market Cap
$235.66M
Current Ratio
1.43
TTM Avg
1.27
3Y Avg
1.29
5Y Avg
1.36
Market Cap
$235.08M
Current Ratio
48.62
TTM Avg
31.63
3Y Avg
25.23
5Y Avg
22.81
Market Cap
$241.34M
Current Ratio
9.97
TTM Avg
9.81
3Y Avg
16.34
5Y Avg
20.09
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Invivyd, Inc. (IVVD) | $237.57M | 5.87 | 4.68 | 4.85 | 7.09 |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | 17.19 | 13.55 | 8.08 | 8.08 |
| High Tide Inc. (HITI)vs › | $239.01M | 1.50 | 1.39 | 1.25 | 1.14 |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 8.28 | 3.73 | 7.03 | 8.20 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 21.72 | 10.47 | 8.50 | 9.09 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 1.43 | 1.27 | 1.29 | 1.36 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 48.62 | 31.63 | 25.23 | 22.81 |
| Quantum-Si incorporated (QSI)vs › | $241.34M | 9.97 | 9.81 | 16.34 | 20.09 |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 20.30 | 4.91 | 4.89 | 6.73 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | 3.87 | 3.17 | 2.70 | 2.15 |
Current Ratio
5.87
Quick Ratio
5.86
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.87 |
| 2026-03-31 | 6.47 |
| 2025-12-31 | 7.24 |
| 2025-09-30 | 2.47 |
| 2025-06-30 | 1.33 |
| 2025-03-31 | 1.53 |
| 2024-12-31 | 1.62 |
| 2024-09-30 | 1.92 |
| 2024-06-30 | 4.71 |
| 2024-03-31 | 5.77 |
| 2023-12-31 | 4.47 |
| 2023-09-30 | 10.08 |
| 2023-06-30 | 9.54 |
| 2023-03-31 | 15.62 |
| 2022-12-31 | 15.06 |
| 2022-09-30 | 9.14 |
| 2022-06-30 | 7.09 |
| 2022-03-31 | 5.80 |
| 2021-12-31 | 9.94 |
| 2021-09-30 | 12.82 |
| 2021-06-30 | 10.45 |
| 2021-03-31 | 3.31 |
| 2020-12-31 | 8.98 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
